1-161306722-T-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM5PP5_Very_Strong
The NM_000530.8(MPZ):c.434A>C(p.Tyr145Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y145C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000530.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MPZ | NM_000530.8 | c.434A>C | p.Tyr145Ser | missense_variant | 3/6 | ENST00000533357.5 | |
MPZ | NM_001315491.2 | c.434A>C | p.Tyr145Ser | missense_variant | 3/6 | ||
MPZ | XM_017001321.3 | c.464A>C | p.Tyr155Ser | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MPZ | ENST00000533357.5 | c.434A>C | p.Tyr145Ser | missense_variant | 3/6 | 1 | NM_000530.8 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152110Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251494Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135922
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461866Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 727230
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152110Hom.: 0 Cov.: 29 AF XY: 0.0000807 AC XY: 6AN XY: 74304
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 05, 2021 | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant associates with disease in multiple families. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant results in abnormal protein function by causing protein to be retained in the endoplasmic reticulum (ER) rather than being transported to the cell membrane or myelin sheath (PMID 29687021). The variant is located in a region that is considered important for protein function and/or structure. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 17, 2021 | Published functional studies demonstrate that the variant alters normal MPZ function (Bai et al., 2018); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant does not alter protein structure/function; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Reported in a family with peripheral neuropathy and deafness (Starr et al., 2003); This variant is associated with the following publications: (PMID: 29687021, 30677751, 12805115, 26310628, 20461396, 12845552) - |
Dejerine-Sottas disease;C0205713:Roussy-Lévy syndrome;C0270912:Charcot-Marie-Tooth disease type 1B;C1843075:Charcot-Marie-Tooth disease dominant intermediate D;C1843153:Charcot-Marie-Tooth disease type 2J;C3888087:Charcot-Marie-Tooth disease type 2I;C4721436:Charcot-Marie-Tooth disease type 4E Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Charcot-Marie-Tooth disease type 1B Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2003 | - - |
MPZ-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 29, 2023 | The MPZ c.434A>C variant is predicted to result in the amino acid substitution p.Tyr145Ser. This variant has been reported in multiple individuals with autosomal dominant Charcot-Marie-Tooth disease (Leal et al 2003. PubMed ID: 12845552; Starr et al. 2003. PubMed ID: 12805115; Taniguchi T et al 2020. PubMed ID: 33179255). An in vitro experimental study suggests this variant impacts protein localization leading to increased endoplasmic reticulum retention (Bai et al. 2018. PubMed ID: 29687021). This variant is reported in 0.014% of alleles in individuals of Latino descent in gnomAD and is reported in ClinVar as pathogenic by several outside laboratories (http://gnomad.broadinstitute.org/variant/1-161276512-T-G; https://www.ncbi.nlm.nih.gov/clinvar/variation/14191/). Given the evidence, this variant is interpreted as pathogenic. - |
Charcot-Marie-Tooth disease, type I Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 145 of the MPZ protein (p.Tyr145Ser). This variant is present in population databases (rs121913603, gnomAD 0.01%). This missense change has been observed in individual(s) with hereditary peripheral neuropathy and hereditary sensory motor neuropathy with deafness (PMID: 12805115, 12845552). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 14191). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MPZ protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at